Evidence map›Paper›PMID 39915805›Full record

ArticleParasites & vectors2025

Evaluation of dried blood spot sampling for real-time PCR malaria diagnostics in a rural setting in Angola.

Alejandro Mediavilla, Begoña Febrer-Sendra, Aroa Silgado, Patricia Martínez-Vallejo, Beatriz Crego-Vicente, Arlette Nindia, Carles Rubio Maturana, Lidia Goterris, Joan Martínez-Campreciós, Sandra Aixut and 6 more

Abstract readEvaluation Study
In one paragraph

Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Alejandro MediavillaMicrobiology Department, Vall d'Hebron University Hospital, Autonomous University of Barcelona, PROSICS Barcelona, Barcelona, Spain.
Begoña Febrer-SendraInfectious and Tropical Diseases Research Group (E-INTRO), Biomedical Research Institute of Salamanca-Center for Research in Tropical Diseases of the University of Salamanca (IBSAL-CIETUS), Faculty of Pharmacy, University of Salamanca, Salamanca, Spain.
Aroa SilgadoMicrobiology Department, Vall d'Hebron University Hospital, Autonomous University of Barcelona, PROSICS Barcelona, Barcelona, Spain.
Patricia Martínez-VallejoMicrobiology Department, Vall d'Hebron University Hospital, Autonomous University of Barcelona, PROSICS Barcelona, Barcelona, Spain.
Beatriz Crego-VicenteInfectious and Tropical Diseases Research Group (E-INTRO), Biomedical Research Institute of Salamanca-Center for Research in Tropical Diseases of the University of Salamanca (IBSAL-CIETUS), Faculty of Pharmacy, University of Salamanca, Salamanca, Spain.
Arlette NindiaHospital Nossa Senhora da Paz, Cubal, Angola.
Carles Rubio MaturanaMicrobiology Department, Vall d'Hebron University Hospital, Autonomous University of Barcelona, PROSICS Barcelona, Barcelona, Spain.
Lidia GoterrisMicrobiology Department, Vall d'Hebron University Hospital, Autonomous University of Barcelona, PROSICS Barcelona, Barcelona, Spain.
Joan Martínez-CampreciósCentro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Sandra AixutInternational Health Unit Vall d'Hebron-Drassanes, Infectious Diseases Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain.
Pedro Fernández-SotoInfectious and Tropical Diseases Research Group (E-INTRO), Biomedical Research Institute of Salamanca-Center for Research in Tropical Diseases of the University of Salamanca (IBSAL-CIETUS), Faculty of Pharmacy, University of Salamanca, Salamanca, Spain.
María Luisa AznarCentro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Antonio MuroInfectious and Tropical Diseases Research Group (E-INTRO), Biomedical Research Institute of Salamanca-Center for Research in Tropical Diseases of the University of Salamanca (IBSAL-CIETUS), Faculty of Pharmacy, University of Salamanca, Salamanca, Spain.
Inés Oliveira-SoutoCentro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Israel MolinaCentro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Elena SulleiroMicrobiology Department, Vall d'Hebron University Hospital, Autonomous University of Barcelona, PROSICS Barcelona, Barcelona, Spain. elena.sulleiro@vallhebron.cat.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMalaria is the parasitic disease with the highest morbidity and mortality worldwide. Angola is one of the five sub-Saharan African countries with the highest malaria burden. Real-time PCR diagnosis in endemic areas has not been implemented due to its high cost and the need for adequate infrastructure. Dried blood spots (DBSs) are an alternative for collecting, preserving, and transporting blood samples to reference laboratories. The objective of the study was to assess the efficacy of DBS as a sampling method for malaria research studies employing real-time PCR.

methodsThe study was divided into two phases: (i) prospective study at the Hospital Universitario Vall d'Hebron (HUVH) to compare real-time PCR from whole blood or DBS, including 12 venous blood samples from patients with positive real-time PCR for Plasmodium spp. and 10 quality control samples (nine infected samples and one negative control). Samples were collected as DBSs (10, 20, 50 µl/circle). Samples from both phases of the study were analyzed by generic real-time PCR (Plasmodium spp.) and the subsequent positive samples underwent species-specific real-time PCR (Plasmodium species) and (ii) cross-sectional study conducted at the Hospital Nossa Senhora da Paz, Cubal (Angola), including 200 participants with fever. For each patient, a fresh capillary blood specimen [for thin and thick blood films and rapid diagnostic test (RDT)] and venous blood, collected as DBSs (two 10-µl circles were combined for a total volume of 20 µl of DBS), were obtained. DBSs were sent to HUVH, Barcelona, Spain.

results(i) Real-time PCR from whole blood collection was positive for 100% of the 21 Plasmodium spp.-infected samples, whereas real-time PCR from DBSs detected Plasmodium spp. infection at lower proportions: 76.19% (16/21) for 10 µl, 85.71% (18/21) for 20 µl, 88.24% (15/17) for 50 µl and 85.71% (18/21) for 100 µl DBSs. (ii) Field diagnosis (microscopy and/or RDT) showed a 51.5% (103/200) positivity rate, while 50% (100/200) of the DBS samples tested positive by real-time PCR. Using field diagnosis as the reference method, the sensitivity of real-time PCR in DBS samples was 77.67% with a specificity of 79.38%. Plasmodium species were identified in 86 samples by real-time PCR: 81.40% (16/86) were caused by Plasmodium falciparum, 11.63% (10/86) were coinfections of P. falciparum + P. malariae, 4.65% (4/86) were P. falciparum + P. ovale, and 2.33% (2/86) were triple coinfections.

conclusionsThe DBS volume used for DNA extraction is a determining factor in the performance of real-time PCR for Plasmodium DNA detection. A DBS volume of 50-100 µl appears to be optimal for malaria diagnosis and Plasmodium species determination by real-time PCR. DBS is a suitable method for sample collection in Cubal followed by real-time PCR analysis in a reference laboratory.

Indexed as

Dried Blood Spot TestingMalariaPlasmodiumReal-Time Polymerase Chain ReactionSpecimen HandlingAdolescentAdultAngolaChildChild, PreschoolCross-Sectional StudiesFemaleHumansMaleMiddle AgedProspective StudiesDiagnosisDried blood spotsMalariaReal-time PCRSamplingWhole blood

Identifiers

PMID39915805
PMCPMC11803990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.